Azenta (NASDAQ:AZTA – Free Report) had its price target hoisted by Jefferies Financial Group from $44.00 to $52.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. Jefferies Financial Group currently has a buy rating on the stock.
Several other analysts have also weighed in on the stock. Weiss Ratings upgraded shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. Wall Street Zen cut shares of Azenta from a “buy” rating to a “hold” rating in a report on Sunday, October 18th. Finally, Needham & Company LLC restated a “buy” rating and issued a $37.00 price target on shares of Azenta in a research report on Monday, September 14th. Four analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $43.60.
Check Out Our Latest Research Report on Azenta
Azenta Trading Up 20.8%
Shares of AZTA opened at $48.90 on Wednesday. The firm has a market cap of $2.14 billion, a price-to-earnings ratio of -13.51 and a beta of 1.47. The stock has a 50 day moving average of $35.98 and a 200-day moving average of $28.51. Azenta has a 52 week low of $15.93 and a 52 week high of $50.06.
Azenta (NASDAQ:AZTA – Get Free Report) last issued its quarterly earnings results on Tuesday, November 10th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.17. Azenta had a positive return on equity of 1.37% and a negative net margin of 26.86%. The business had revenue of $167.09 million during the quarter, compared to the consensus estimate of $160.16 million.
Institutional Trading of Azenta
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Green Alpha Advisors LLC boosted its position in Azenta by 3.5% during the 3rd quarter. Green Alpha Advisors LLC now owns 9,187 shares of the company’s stock valued at $321,000 after purchasing an additional 313 shares during the period. Global Retirement Partners LLC grew its stake in Azenta by 82.3% during the 3rd quarter. Global Retirement Partners LLC now owns 771 shares of the company’s stock worth $27,000 after buying an additional 348 shares during the last quarter. Allworth Financial LP grew its stake in Azenta by 27.9% during the 3rd quarter. Allworth Financial LP now owns 2,421 shares of the company’s stock worth $84,000 after buying an additional 528 shares during the last quarter. Illinois Municipal Retirement Fund increased its position in Azenta by 2.8% in the third quarter. Illinois Municipal Retirement Fund now owns 22,864 shares of the company’s stock worth $798,000 after buying an additional 620 shares during the period. Finally, Heritage Family Offices LLP acquired a new stake in Azenta in the third quarter worth $31,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.
Trending Headlines about Azenta
Here are a few of the latest headlines about AZTA:
- Positive Sentiment: Azenta reported Q4 adjusted EPS of $0.28 versus $0.11 expected and revenue of $167.1 million versus about $160.2 million expected. FY2027 revenue guidance of $648–$660 million is above the $632.4 million consensus; the company also forecast 3%–5% organic growth and 200–250 basis points of adjusted EBITDA margin expansion. Azenta fiscal 2026 results and FY2027 outlook
- Positive Sentiment: Jefferies raised its price target from $44 to $52 and maintained a Buy rating, signaling improved analyst expectations following the results. Jefferies recommendations
- Negative Sentiment: Rosen Law Firm said it is investigating potential securities claims related to allegations that Azenta may have provided materially misleading business information. The claims are allegations, not established findings, but the investigation adds legal uncertainty. Rosen Law Firm investigation announcement
About Azenta
Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.
Read More
- Five stocks we like better than Azenta
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.
